Table 3 Mean, median and [min–max] for explanatory variables associated with Altmetric score (n = 792)

Study design

SR/MA

14.9 (37.0)

3.5 [1.0–10.0]

[0.0–268.0]

RCT

20.7 (50.5)

3.0 [0.0–16.0]

[0.0–428.0]

Phase I/II, non-RCT

6.5 (17.2)

2.0 [0.0–4.0]

[0.0–139.0]

Observational study

13.4 (39.7)

2.0 [0.0–7.0]

[0.0–319.0]

Abstract conclusion

In favour of study treatment

16.6 (44.8)

2.0 [0.0–9.0]

[0.0–428.0]

Not in favour of study treatment

11.5 (32.5)

2.0 [0.0–7.0]

[0.0–319.0]

Funding source

Profit

13.9 (41.1)

2.0 [0.0–9.0]

[0.0–370.0]

Non-profit

15.4 (41.1)

2.0 [0.0–8.0]

[0.0–428.0]

Open access

Yes

17.9 (49.3)

3.0 [1.0–8.0]

[0.0–428.0]

No

10.6 (24.8)

1.5 [0.0–8.0]

[0.0–258.0]

Press release

Yes

118.6 (87.5)

84.5 [58.0–144.5]

[29.0–428.0]

No

7.0 (19.0)

2.0 [0.0–5.0]

[0.0–268.0]